Cargando…

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children

The novel coronavirus, known as 2019-nCoV or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused an epidemic with high mortality and morbidity since December 2019, in Wuhan, China. The infection has now been transmitted to more than 210 countries worldwide and caused more than 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Aleebrahim-Dehkordi, Elahe, Soveyzi, Faezeh, Deravi, Niloofar, Rabbani, Zahra, Saghazadeh, Amene, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580518/
https://www.ncbi.nlm.nih.gov/pubmed/33186866
http://dx.doi.org/10.1016/j.pedn.2020.10.020
_version_ 1783598808372871168
author Aleebrahim-Dehkordi, Elahe
Soveyzi, Faezeh
Deravi, Niloofar
Rabbani, Zahra
Saghazadeh, Amene
Rezaei, Nima
author_facet Aleebrahim-Dehkordi, Elahe
Soveyzi, Faezeh
Deravi, Niloofar
Rabbani, Zahra
Saghazadeh, Amene
Rezaei, Nima
author_sort Aleebrahim-Dehkordi, Elahe
collection PubMed
description The novel coronavirus, known as 2019-nCoV or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused an epidemic with high mortality and morbidity since December 2019, in Wuhan, China. The infection has now been transmitted to more than 210 countries worldwide and caused more than 200,000 deaths. Similar to other coronaviruses such as Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), SARS-CoV-2 appears to less commonly affect pediatrics and to cause less severe disease along with fewer symptoms compared to adults. Available data suggest that the pediatric population is just as likely as adults to become infected with SARS-CoV-2. However, they may be asymptotic or have milder symptoms than adults; they can be potential carriers of the disease. This article reviews the present understanding of SARS-CoV-2 infection in the pediatric age group in comparison with MERS-CoV and SARS-CoV.
format Online
Article
Text
id pubmed-7580518
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-75805182020-10-23 Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children Aleebrahim-Dehkordi, Elahe Soveyzi, Faezeh Deravi, Niloofar Rabbani, Zahra Saghazadeh, Amene Rezaei, Nima J Pediatr Nurs Article The novel coronavirus, known as 2019-nCoV or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused an epidemic with high mortality and morbidity since December 2019, in Wuhan, China. The infection has now been transmitted to more than 210 countries worldwide and caused more than 200,000 deaths. Similar to other coronaviruses such as Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), SARS-CoV-2 appears to less commonly affect pediatrics and to cause less severe disease along with fewer symptoms compared to adults. Available data suggest that the pediatric population is just as likely as adults to become infected with SARS-CoV-2. However, they may be asymptotic or have milder symptoms than adults; they can be potential carriers of the disease. This article reviews the present understanding of SARS-CoV-2 infection in the pediatric age group in comparison with MERS-CoV and SARS-CoV. Elsevier Inc. 2021 2020-10-22 /pmc/articles/PMC7580518/ /pubmed/33186866 http://dx.doi.org/10.1016/j.pedn.2020.10.020 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Aleebrahim-Dehkordi, Elahe
Soveyzi, Faezeh
Deravi, Niloofar
Rabbani, Zahra
Saghazadeh, Amene
Rezaei, Nima
Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
title Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
title_full Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
title_fullStr Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
title_full_unstemmed Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
title_short Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
title_sort human coronaviruses sars-cov, mers-cov, and sars-cov-2 in children
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580518/
https://www.ncbi.nlm.nih.gov/pubmed/33186866
http://dx.doi.org/10.1016/j.pedn.2020.10.020
work_keys_str_mv AT aleebrahimdehkordielahe humancoronavirusessarscovmerscovandsarscov2inchildren
AT soveyzifaezeh humancoronavirusessarscovmerscovandsarscov2inchildren
AT deraviniloofar humancoronavirusessarscovmerscovandsarscov2inchildren
AT rabbanizahra humancoronavirusessarscovmerscovandsarscov2inchildren
AT saghazadehamene humancoronavirusessarscovmerscovandsarscov2inchildren
AT rezaeinima humancoronavirusessarscovmerscovandsarscov2inchildren